Tag: Lomonosov Moscow State University

Nacimbio and Lomonosov MSU to develop new immunobiological preparations

Pharmaceutical Holding State Corporation Rostec 'Nacimbio' and M.V. Lomonosov Moscow State University agreed on long-term cooperation in the development of innovative immunobiological drugs.

Primer Capital and Bayer become partners to support biotech startups

Primer Capital, a venture capital biotech fund, and Bayer have signed an agreement on the joint work to identify and develop the promising startups

A new antioxidant may become the basis for a diabetic wound healing drug

The researchers at the Faculty of Biology and A.N. Belozersky Institute Of Physico-Chemical Biology in M.V. Lomonosov Moscow State University used a mouse model to test SkQ1